Skip to main content
BTC / USDT——ETH / USDT——SOL / USDT——BNB / USDT——XRP / USDT——DOGE / USDT——TON / USDT——AVAX / USDT——LINK / USDT——ADA / USDT——TRX / USDT——DOT / USDT——BTC / USDT——ETH / USDT——SOL / USDT——BNB / USDT——XRP / USDT——DOGE / USDT——TON / USDT——AVAX / USDT——LINK / USDT——ADA / USDT——TRX / USDT——DOT / USDT——
Pricing
stocksJul 29, 2026, 9:29 PM

Johnson & Johnson Gets Exclusive Option to Buy Sail Biomedicines for $2.58 Billion

J&J has secured an exclusive option to acquire Sail Biomedicines for $2.58 billion along with an equity investment, with initial payments of $785 million, per an SEC filing.

JNJ

Johnson & Johnson has entered into strategic agreements with Sail Biomedicines, granting the healthcare giant an exclusive option to purchase the company. The deal, disclosed in an SEC filing, values the potential acquisition at $2.58 billion.

In addition to the option, J&J has made an equity investment in Sail Biomedicines. Total initial payments amount to $785 million, though further financial details were not immediately available.

The filing did not provide a timeline for the possible acquisition or specify the therapeutic areas involved. Sail Biomedicines is a biotech firm, but no further details about its pipeline were included in the announcement.

Source: First Squawk